Mesenchymal Stem Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa: Prospects and Clinical Progress

Expert Opinion on Orphan Drugs - United Kingdom
doi 10.1517/21678707.2016.1152886
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Recessive Dystrophic Epidermolysis Bullosa Inversa

2020English

Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa

New England Journal of Medicine
Medicine
2010English

Induced Pluripotent Stem Cells From Individuals With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2011English

271 From Clinical to Genotypic Modeling: Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

1021 Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa Patients Harboring Nonsense Mutations

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Generation of Keratinocytes From Normal and Recessive Dystrophic Epidermolysis Bullosa-Induced Pluripotent Stem Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Translating the Combination of Gene Therapy and Tissue Engineering for Treating Recessive Dystrophic Epidermolysis Bullosa

2018English

1039 Novel Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

935 Clinical Manifestations and Quality of Life in Patients With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy